From cancer screening to pharmacogenomics — deploy a complete genomic service line with TGB's platform, lab partnerships, and AI. We handle the science. You own the patient relationship.
Patients asking for genetic testing but your lab doesn't offer it
Oncology needs hereditary cancer screening — building in-house takes 18+ months
PGx could reduce adverse drug events but there's no integration with your pharmacy workflow
Competitors are marketing 'precision health' and you're falling behind
No internal bioinformatics team to interpret raw genomic data
Regulatory complexity around genetic counselling requirements
We don't sell you everything at once. Here's the stack built for your specific needs — from entry point to full platform.
Lead with clinical genomics — 18 cancers, 3,000+ rare diseases, PGx. Highest clinical seriousness builds trust for the entire brand.
Universal entry — AI overlay on blood work you already do. Zero capex. Gets genomics into every department at $3-5/report.
Wellness wing expansion — longevity, nutrigenomics, sports for your preventive care and executive health programmes.
Platform layer — integrates into your LIS/EHR via HL7/FHIR. White-label reports. Genetic counselling summaries auto-generated.
Revenue model: per-test pricing with volume tiers. Platform fee for LIS integration and white-label deployment. Typical hospital chain sees 3–5x ROI within the first year through new service line revenue and reduced adverse drug events via PGx.
Map your service lines, patient volumes, and clinical priorities.
Select the right product mix and integration approach for your LIS.
Launch with one department. Validate workflows and measure outcomes.
Expand across departments, add products, train clinical teams.
Map your service lines, patient volumes, and clinical priorities.
Select the right product mix and integration approach for your LIS.
Launch with one department. Validate workflows and measure outcomes.
Expand across departments, add products, train clinical teams.
5-10% of ALL cancers are hereditary. Offering cancer screening + PGx = the highest clinical seriousness service — which makes it the highest trust builder for the whole hospital brand. TGB is recommended by Illumina and ThermoFisher, holds a 5-year MOU for 10,000 Olympic athletes, and operates across 39 partners in 11 countries.
The combination of clinical-grade genomics with AI interpretation gives our oncology department confidence in every recommendation. The PGx module alone has changed how we approach first-line therapy.
See a live demo tailored to your exact use case and patient volume.
